Biotechnology

Cambridge biotech to unveil AI-powered LNP platform at ASGCT 2026, targeting fat and T-cells to unlock new treatments for obesity and cancer.

Umoja Biopharma's UB-VV500 aims to revolutionize myeloma care by creating a dual-antigen CAR T therapy directly inside the patient's body.

A new therapy programs immune cells inside the body to fight disease. Sail Biomedicines is pioneering this approach to offer a potential cure for autoimmunity.

A new grant from Zymo Research aims to solve a key data problem in gut science, potentially unlocking the next wave of breakthroughs in personalized medicine.

New Phase 2a data reveals Oruka Therapeutics' ORKA-001 achieved complete skin clearance in nearly two-thirds of patients, positioning it as a potential game-changer.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

A UK firm's breakthrough blood test for early breast cancer detection joins a prestigious EU network, aiming to personalize treatment and redefine diagnostics.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

A financially struggling healthcare firm makes a bold leap into neurotechnology, but can it compete with giants like Neuralink in the high-risk BCI race?

A new long-term deal for the INTERCEPT system highlights a critical shift towards proactive pathogen reduction to protect France's blood supply from global threats.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

In a key human trial, Sona Nanotech's heat-based therapy saw a 60% complete response in tumors for melanoma patients who had exhausted other options.

NerView Surgical's NerveSense™ wins FACIT's top award, spotlighting a growing ecosystem making Ontario a global leader in oncology innovation.

By emphasizing deep anatomical knowledge, Medytox aims to elevate industry standards and solidify its leadership in Asia's booming medical aesthetics market.

BrioHealth Solutions gets an FDA nod for a trial of its BrioVAD, a miniaturized heart pump designed for children with advanced heart failure.

A revolutionary organ preservation system is showing 100% graft survival in new studies, promising to expand the donor pool for children in need.

CHINAPLAS 2026 preview reveals a strategic shift to bio-materials, smart factories, and deep alignment with China's ambitious industrial roadmap.

H1 launched its Site Network Suite, an AI platform promising to slash clinical trial feasibility times and reshape how sponsors and research sites connect.

With its CMO and CSO now both recipients of the AHA's top honor, Cardiovascular Clinical Sciences signals a rare concentration of elite expertise.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.